Loading clinical trials...
Loading clinical trials...
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Conditions
Interventions
Somatuline Autogel (lanreotide acetate)
Home administration
Locations
13
United States
Diabetes and Endocrine Associates
La Mesa, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Denver VA Medical Center
Denver, Colorado, United States
Northwestern University The Feinberg School of Medicine
Chicago, Illinois, United States
Johns Hopkins University
Baltimore, Maryland, United States
Massachussetts General Hospital
Boston, Massachusetts, United States
Start Date
April 1, 2007
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2008
Last Updated
November 20, 2020
NCT00001595
NCT04837040
NCT04125836
NCT06253897
NCT02611336
NCT05184231
Lead Sponsor
Ipsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions